Results 221 to 230 of about 156,800 (338)

N-Methyl-D-aspartic acid receptor (NMDAR); glutamate receptor, ionotropic, N-methyl-D-aspartate 2B (GRIN2B; NR2B) [PDF]

Science-Business eXchange, 2009
openaire   +1 more source

Anti‑N‑ Methyl‑ D‑ Aspartate Receptor Encephalitis

Česká a slovenská neurologie a neurochirurgie, 2014
Zuzana Libá, Jitka Hanzalová, Věra Sebroňová, Vladimír Komárek   +3 more
openaire   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Evaluation of preclinical antipsychotic models used to support first‐in‐human clinical trials

British Journal of Pharmacology, EarlyView.
Abstract Schizophrenia is regarded as a complex and heterogeneous psychiatric disorder, characterised by diverse symptoms and comorbidities, which complicate both clinical management and drug development. Current pharmacological treatment, primarily based on dopamine D2 receptor antagonism or partial agonism, which has not markedly progressed since the
Thi Viet Ha Nguyen, Declan P. McKernan, John P. Kelly   +2 more
wiley   +1 more source

Elevated Prolactin Levels Are Associated With Increased Severity and Psychiatric Symptoms in Anti-N-Methyl-D-Aspartate Receptor Encephalitis. [PDF]

Brain Behav
Ma X, Lu Y, Xu Y, Guo S, Wang W, Shang W, Qiu W, Wang P, Shu Y, Wang Y.   +9 more
europepmc   +1 more source

The endocytic receptor protein LRP also mediates neuronal calcium signaling via N-methyl-D-aspartate receptors.

Proceedings of the National Academy of Sciences of the United States of America, 2000
B. Bacskai, M. Xia, D. Strickland, G. Rebeck, B. Hyman   +4 more
semanticscholar   +1 more source

Vesicular glutamate transporter VGLUT2 expression emerges in substantia nigra dopamine neurons in mouse models of parkinsonism in the absence of neurodegeneration

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Subsets of midbrain dopamine (DA) neurons express the vesicular glutamate transporter VGLUT2 and can release the excitatory neurotransmitter glutamate. VGLUT2+ DA neurons of the substantia nigra pars compacta (SNc) were shown to be more resistant to neurodegeneration in animal models of Parkinson's disease (PD ...
Sivakumar Srinivasan, Christian Pifl, Thomas Steinkellner   +2 more
wiley   +1 more source

Zinc, copper, and magnesium in premenstrual disorders: a narrative review. [PDF]

Pharmacol Rep
Krupa AJ, Zybała-Pawłowska M, Kania M, Turek J, Szewczyk B, Grabrucker AM, Siwek M.   +6 more
europepmc   +1 more source

N-Methyl-d-aspartic acid receptor (NMDAR) [PDF]

Science-Business eXchange, 2008
openaire   +1 more source

Myeloid PD‐1 Regulates Astrocyte Development and Leads to Active Behaviours

Cell Proliferation, EarlyView.
During early neurodevelopment, PD‐1 ablation in myeloid cells influences myeloid proliferation/differentiation and causes sustained astrocyte overproliferation. PD‐1f/f; LysM‐Cre mice showed elevated astrocyte gene expression and behavioural changes.
Jie Qin, Chong Wang, Sihan Li, Yanyan Wang, Tingting He, Jianwei Jiao, Fen Ji   +6 more
wiley   +1 more source